Century Therapeutics (IPSC) Other Accumulated Expenses (2022 - 2025)
Century Therapeutics (IPSC) posted quarterly Other Accumulated Expenses of $1.0 million for Q3 2025, up 1132.14% year-over-year from $84000.0 in Q3 2024, and up 2012.24% quarter-over-quarter from $49000.0 in Q2 2025.
Powered by 
Analysis
Century Therapeutics (IPSC) Other Accumulated Expenses (2022 - 2025) Analysis & Trends
Century Therapeutics (IPSC) has reported Other Accumulated Expenses for 4 consecutive years, with $1.0 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Other Accumulated Expenses rose 1132.14% year-over-year to $1.0 million; the TTM figure through Sep 2025 stood at $1.0 million (up 1132.14% YoY), while the FY2024 annual figure was $75000.0, up 167.86% from the prior year.
- Other Accumulated Expenses rose to $1.0 million in Q3 2025 per IPSC's latest filing, from $49000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $1.0 million in Q3 2025 and bottomed at $11000.0 in Q2 2023.
- Historically, Other Accumulated Expenses has averaged $164000.0 across 4 years, with a median of $75000.0 in 2024.
- Annual changes were most pronounced in 2023 — Other Accumulated Expenses slumped 88.14% — and 2025, when it soared 1132.14%.
- Century Therapeutics' Other Accumulated Expenses stood at $236000.0 in 2022, then plunged by 88.14% to $28000.0 in 2023, then surged by 167.86% to $75000.0 in 2024, then surged by 1280.0% to $1.0 million in 2025.
- Business Quant data shows IPSC's Other Accumulated Expenses at $1.0 million in Q3 2025, $49000.0 in Q2 2025, and $111000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Century Therapeutics | 440.37 Mn | 180.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 49,000.00 |
| Mar 31, 2025 | 111,000.00 |
| Dec 31, 2024 | 75,000.00 |
| Sep 30, 2024 | 84,000.00 |
| Jun 30, 2024 | 108,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 28,000.00 |
| Sep 30, 2023 | 17,000.00 |
| Jun 30, 2023 | 11,000.00 |
| Dec 31, 2022 | 236,000.00 |